28th
28th Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology jointly with 48th Annual Meeting of Japanese Society of Newropsychopharmacology
November 14-16, 2018
Tokyo Dome Hotel ,Tokyo ,Japan
| FIRST AUTHOR INDEX | |||
|---|---|---|---|
| First Name | Last Name | No. | Title |
| Joseph | R.Joseph | SL | Recognition, Treatment, Morbidity and Mortality in Bipolar Disorder |
| TOMIKI | SUMIYOSHI | JS5-2 | Cognitive impairment in mood disorders; its assessment and therapeutics |
| TADAFUMI | KATO | S8-1 | Phenotypic discordance of iPS cells-derived neurons/cerebral organoids between monozygotic twins discordant for schizoaffective bipolar disorder |
| HARUHISA | INOUE | S8-4 | Disease modeling and drug discovery using iPSC platform |
| KAZUHIRO | HAYASHI | S20-2 | Game change of scholarly communication enhanced by Open Science and its policy |
| TOSHIAKI | FURUKAWA | PJ1 | Comparative efficacy and acceptability of 21 antidepressantdrugs for the acute treatment of adults with major depressive disorder: a systematic reviewand network meta-analysis |
| SAKI | HATTORI | EN2 | Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia |
| KENTARO | ONIKI | EN3 | Association between oxidative stress-related genes polymorphisms and metabolic abnormalities among schizophrenia patients |
| Shitij | Kapur | LS1-3 | Dopamine and Antipsychotics:Past, Present and Future |
| Joseph | R.Calabrese | LS2-1 | Early Intervention in the Diagnosis and Treatment of Bipolar Disorder and Schizophrenia |
| Mark | Zimmerman | SS2-1 | Things That You Think You Know That May Not Be True in the Diagnosis and Treatment of Depression |
| KAZUNARI | YOSHIDA | O2-3 | A preliminary multi-genic prediction model for antipsychotic-induced weight gain |
| RYOSUKE | ARAKAWA | O3-1 | Norepinephrine transporter occupancy of venlafaxine extended-release in patients with major depressive disorder using positron emission tomography and radioligand [18F]FMeNER-D2 |
| TAKASHI | OHNISHI | O5-1 | Disrupted structural connectivity and less efficient network brain in the schizophrenia revealed by graph theoretical analysis |
| GENTARO | MIURA | O6-2 | Hospitalization-preventing effect of Long-Acting Injectable Versus Oral AntipsychoticsA Retrospective Bidirectional-Mirror-Image Study in Japanese Psychiatric Hospitals |
| YUYA | MIZUNO | O7-4 | Heterogeneity of antipsychotic efficacy in treatment resistant schizophrenia: A meta-analysis |
| FUMIHIKO | UENO | O9-2 | Influence of Alcohol and Acetaldehyde on Human Psychomotor Functions: Findings from the Alcohol Clamping in Healthy Young Population |
| MAKOTO | ISHITOBI | O10-2 | Paroxysmal kinesigenic dyskinesia associated with depression in a bipolar patient with comorbid idiopathic basal ganglia calcification |
| KAOSU | MATSUMORI | O11-2 | A Computational Psychiatric Model with Exponentially Biased Bayesian Inference for Mental Diseases |
| KAZUTAKA | OHI | O12-2 | Genome-wide variants shared between smoking quantity and schizophrenia on 15q25 are associated with CHRNA5 expression in the brain |
| Marco | Riva | O12-3 | Anti-stress and neuroplastic effects of blonanserin in preclinical models |
| YOKI | NAKAMURA | O13-2 | Sigma-1 receptor plays a key role in the control of extracellular vesicle release by modulating the activity of the ADP-Ribosylation Factor 6 at the mitochondrion-endoplasmic reticulum interface |
| SHINICHIRO | NAKAJIMA | O14-1 | Glutamatergic Neurometabolite Levels in Major Depressive Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies |
| TAKUMA | INAGAWA | P1-4 | A meta-analysis of the effects of multi-session transcranial direct current stimulation on cognition in dementia and mild cognitive impairment. |
| TAKASHI | OHNISHI | P3-2 | The large scale disturbed white matter fibre in schizophrenia revealed by local connectometry |
| YUZURU | KATAOKA | P4-4 | Difference in executive function among with patients with schizophrenia, their first degree relatives and healthy subjects |
| YUSUKE | IWATA | P6-1 | Glutamatergic Neurometabolite Levels in Patients with Ultra Treatment-Resistant Schizophrenia: a Cross-sectional 3T Proton MRS study |
| KEN | INADA | P6-5 | Analysis of clozapine use and safety using comprehensive national data from the Japanese Clozapine Patient Monitoring Service |
| SHIN | KUROSE | P7-1 | Time Courses of Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentrations of Antipsychotics: A Systematic Review |
| SAKI | HATTORI | P9-5 | Associations of ABCB1 gene polymorphisms with aripiprazole-induced autonomic nervous system dysfunction in schizophrenia |
| KYOSUKE | SAWADA | P14-1 | Impact of subjective vs. objective remission status on subjective cognitive impairments in depression |
| Cynthia | Siu | P19-1 | NETWORK MODEL OF DEPRESSIVE AND MANIC SYMPTOMS IN THE STEP-BD STUDY |
| TOSHINORI | SHIRATA | P27-6 | Relationship of high neuroticism with increased methylation of the BDNF gene in healthy subjects |